173 related articles for article (PubMed ID: 31696478)
1. SP1-regulated LINC01638 promotes proliferation and inhibits apoptosis in non-small cell lung cancer.
Guo L; Fang L; Liu Y
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8913-8920. PubMed ID: 31696478
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of LINC00346 inhibits proliferation of non-small cell lung cancer cells through mediating JAK-STAT3 signaling pathway.
Wang F; Chen JG; Wang LL; Yan ZZ; Chen SP; Wang XG
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5135-5142. PubMed ID: 29228425
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA ASAP1-IT1 promotes cell proliferation, invasion and metastasis through the PTEN/AKT signaling axis in non-small cell lung cancer.
Zhang L; Shi SB; Zhu Y; Qian TT; Wang HL
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):142-149. PubMed ID: 29364481
[TBL] [Abstract][Full Text] [Related]
4. C-MYC-induced upregulation of LINC01503 promotes progression of non-small cell lung cancer.
Zhang ML; Zhao TT; Du WW; Yang ZF; Peng W; Cui ZJ
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):11120-11127. PubMed ID: 33215429
[TBL] [Abstract][Full Text] [Related]
5. LINC01093 promotes proliferation and invasion of non-small cell lung cancer cells via targeting akt signaling pathway.
Wang ZX; Xu ZN; Sun HB; Wang Y; Han ZF; Yu Y; Han XL; Yin YY; Xu L
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):222-229. PubMed ID: 31957835
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA SNHG15 indicates poor prognosis of non-small cell lung cancer and promotes cell proliferation and invasion.
Dong YZ; Meng XM; Li GS
Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2671-2679. PubMed ID: 29771418
[TBL] [Abstract][Full Text] [Related]
7. LncRNA ASB16-AS1 promotes proliferation and inhibits apoptosis of non small cell lung cancer cells by activating the Wnt/β catenin signaling pathway.
Tan LJ; Liu JT; Yang M; Ju T; Zhang YS
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1870-1876. PubMed ID: 32141556
[TBL] [Abstract][Full Text] [Related]
8. MiR-181a reduces radiosensitivity of non-small-cell lung cancer via inhibiting PTEN.
Chen Y; Liao W; Yuan A; Xu H; Yuan R; Cao J
Panminerva Med; 2022 Sep; 64(3):374-383. PubMed ID: 32506887
[TBL] [Abstract][Full Text] [Related]
9. STAT1-induced upregulation of lncRNA LINP1 promotes cell proliferation and inhibits apoptosis via AMPK signaling pathway in papillary thyroid cancer.
Li HP; Yang TZ; Wei L; Ge YF; Meng QS
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8911-8917. PubMed ID: 32964981
[TBL] [Abstract][Full Text] [Related]
10. LncRNA NNT-AS1 is a major mediator of cisplatin chemoresistance in non-small cell lung cancer through MAPK/Slug pathway.
Cai Y; Dong ZY; Wang JY
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4879-4887. PubMed ID: 30070323
[TBL] [Abstract][Full Text] [Related]
11. LncRNA BC200 regulates the cell proliferation and cisplatin resistance in non-small cell lung cancer via PI3K/AKT pathway.
Gao BB; Wang SX
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1093-1101. PubMed ID: 30779077
[TBL] [Abstract][Full Text] [Related]
12. LncRNA FBXL19-AS1 promotes proliferation and metastasis via regulating epithelial-mesenchymal transition in non-small cell lung cancer.
Yu DJ; Li YH; Zhong M
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4800-4806. PubMed ID: 31210311
[TBL] [Abstract][Full Text] [Related]
13. Long non‑coding RNA FER1L4 inhibits cell proliferation and promotes cell apoptosis via the PTEN/AKT/p53 signaling pathway in lung cancer.
Ouyang L; Yang M; Wang X; Fan J; Liu X; Zhang Y; Shu Y
Oncol Rep; 2021 Jan; 45(1):359-367. PubMed ID: 33416121
[TBL] [Abstract][Full Text] [Related]
14. Effects of Linc00460 on cell migration and invasion through regulating epithelial-mesenchymal transition (EMT) in non-small cell lung cancer.
Yue QY; Zhang Y
Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):1003-1010. PubMed ID: 29509248
[TBL] [Abstract][Full Text] [Related]
15. Linc00703 suppresses non-small cell lung cancer progression by modulating CyclinD1/CDK4 expression.
Sun HB; Han XL; Zhong M; Yu DJ
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):6131-6138. PubMed ID: 32572878
[TBL] [Abstract][Full Text] [Related]
16. LINC01535 promotes proliferation and inhibits apoptosis in esophageal squamous cell cancer by activating the JAK/STAT3 pathway.
Fang Y; Zhang S; Yin J; Shen YX; Wang H; Chen XS; Tang H
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3694-3700. PubMed ID: 32329845
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of lncRNA NCK1-AS1 predicts poor prognosis and contributes to non-small cell lung cancer proliferation by regulating CDK1.
Zha LF; Zhang LD; Pan HM; Ma HD
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1351-1357. PubMed ID: 33629305
[TBL] [Abstract][Full Text] [Related]
18. Influences of LncRNA SNHG20 on proliferation and apoptosis of glioma cells through regulating the PTEN/PI3K/AKT signaling pathway.
Guo LP; Zhang ZJ; Li RT; Li HY; Cui YQ
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):253-261. PubMed ID: 30657567
[TBL] [Abstract][Full Text] [Related]
19. Gastric Adenocarcinoma Predictive Long Intergenic Non-Coding RNA Promotes Tumor Occurrence and Progression in Non-Small Cell Lung Cancer via Regulation of the miR-661/eEF2K Signaling Pathway.
Gu H; Chen J; Song Y; Shao H
Cell Physiol Biochem; 2018; 51(5):2136-2147. PubMed ID: 30522114
[TBL] [Abstract][Full Text] [Related]
20. MiR-411-5p acts as a tumor suppressor in non-small cell lung cancer through targeting PUM1.
Xia LH; Yan QH; Sun QD; Gao YP
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5546-5553. PubMed ID: 30229827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]